KYVERNA THERAPEUTICS, INC.
Lobbying client. Federal LDA filings.
- Source id
69525- General description
- Biopharmaceutical company focused on developing cell therapies for autoimmune diseases.
- State
- CA
- Country
- US
- Principal place of business
- US
- Effective date
- 2025-10-10
- Total spend (across 1 ingested filings)
- $60,000
Filings (1) — $60,000
| Posted | Type | Year | Lobbying firm | Income |
|---|---|---|---|---|
| 2026-04-20 | Q1 | 2026 | AKIN GUMP STRAUSS HAUER & FELD | $60,000 |
Connected on the graph
2 typed relationships in the influence graph — 2 inbound, 0 outbound, grouped by type.
lobbied for (2)
| date | dir | entity | amount | role | source |
|---|---|---|---|---|---|
| — | ← | Anna Abram | — | lda_lobbyist_client | |
| — | ← | Kandis Mcclure | — | lda_lobbyist_client |